108
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Lipid liquid-crystalline nanoparticles sustained teicoplanin delivery for treatment of chronic osteomyelitis: in vitro and in vivo studies

ORCID Icon &
Pages 288-297 | Received 12 Jan 2022, Accepted 25 Apr 2022, Published online: 11 May 2022

References

  • Ambrose, C.G., et al., 2004. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clinical orthopaedics & related research, 421, 293–299.
  • Babul, N., and Pasko, M., 1988. Teicoplanin: a new glycopeptide antibiotic complex. Drug intelligence & clinical pharmacy, 22 (3), 218–226.
  • Barakat, A., et al., 2019. Chronic osteomyelitis: a review on current concepts and trends in treatment. Orthopaedics trauma, 33 (3), 181–187.
  • Barriga, H.M., Holme, M.N., and Stevens, M.M., 2019. Cubosomes: the next generation of smart lipid nanoparticles? Angewandte chemie (international ed. in English), 58 (10), 2958–2978.
  • Bazylińska, U., et al., 2018. Polymer-free cubosomes for simultaneous bioimaging and photodynamic action of photosensitizers in melanoma skin cancer cells. Journal of colloid and interface science, 522, 163–173.
  • Bei, D., et al., 2010. Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization. AAPS pharmscitech, 11 (3), 1243–1249.
  • Bhowmick, M., and Sengodan, T., 2013. Mechanisms, kinetics and mathematical modelling of transdermal permeation-an updated review. International journal of research development in pharmacy, 2 (6), 636–641.
  • Boge, L., et al., 2019. Cubosomes for topical delivery of the antimicrobial peptide LL-37. European journal of pharmaceutics and biopharmaceutics, 134, 60–67.
  • Chaudhary, K., and Sharma, D., 2021. Cubosomes: a potential drug delivery system. Asian journal of pharmaceutical research and development, 9 (5), 93–101.
  • Chime, S.A., and Onyishi, I.V., 2013. Lipid-based drug delivery systems (LDDS): recent advances and applications of lipids in drug delivery. African journal of pharmacy and pharmacology, 7 (48), 3034–3059.
  • Crane, V., and Garabedian-Ruffalo, S., 1992. Current treatment of gram-positive infections: focus on efficacy, safety, and cost minimalization analysis of teicoplanin. Hospital formulary, 27 (12), 1199–1200.
  • de Araújo, D.R., Ribeiro, LNdM., and de Paula, E., 2019. Lipid-based carriers for the delivery of local anesthetics. Expert opinion on drug delivery, 16 (7), 701–714.
  • Duttagupta, A.S., et al., 2016. Cubosomes: innovative nanostructures for drug delivery. Current drug delivery, 13 (4), 482–493.
  • Elakkad, Y.E., et al., 2021. Tenoxicam loaded hyalcubosomes for osteoarthritis. International journal of pharmaceutics, 601, 120483.
  • Estracanholli, É.A., et al., 2014. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies. Aaps pharmscitech, 15 (6), 1468–1475.
  • Flak, D.K., et al., 2020. AT101-loaded cubosomes as an alternative for improved glioblastoma therapy. International journal of nanomedicine, 15, 7415–7431.
  • Fornasier, M., et al., 2020. Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicity. Journal of colloid and interface science, 580, 286–297.
  • Gaballa, S.A., El Garhy, O.H., and Abdelkader, H., 2020. Cubosomes: composition, preparation, and drug delivery applications. Journal of advanced biomedical pharmaceutical sciences, 3 (1), 1–9.
  • Han, S., et al., 2010. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability. Acta pharmacologica sinica, 31 (8), 990–998.
  • Hundekar, Y.R., et al., 2014. Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. World journal of pharmacy pharmaceutical sciences, 3 (1), 523–539.
  • Ijaz, H., et al., 2018. Lipid particulate drug delivery systems: a review. Bioinspired, biomimetic nanobiomaterials, 7 (2), 109–121.
  • Inzana, J.A., et al., 2016. Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials, 81, 58–71.
  • Jia, W.-T., et al., 2010. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta biomaterialia, 6 (3), 812–819.
  • Jorge, L.S., Chueire, A.G., and Rossit, A., 2010. Osteomyelitis: a current challenge. Brazilian journal of infectious diseases, 14 (3), 310–315.
  • Kapoor, K., Pandit, V., and Nagaich, U., 2020. Development and characterization of sustained release methotrexate loaded cubosomes for topical delivery in rheumatoid arthritis. International journal of applied pharmaceutics, 12, 33–39.
  • Kaur, R., and Ajitha, M., 2019. Transdermal delivery of fluvastatin loaded nanoemulsion gel: Preparation, characterization and in vivo anti-osteoporosis activity. European journal of pharmaceutical sciences, 136, 104956.
  • Khan, S., et al., 2018. Topical delivery of erythromycin through cubosomes for acne. Pharmaceutical nanotechnology, 6 (1), 38–47.
  • Lazzarini, L., Lipsky, B.A., and Mader, J.T., 2005. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? International journal of infectious diseases, 9 (3), 127–138.
  • Li, J.-C., et al., 2015. Self-assembled cubic liquid crystalline nanoparticles for transdermal delivery of paeonol. Medical science monitor, 21, 3298–3310.
  • Li, Y., et al., 2019. PH responsiveness of hexosomes and cubosomes for combined delivery of Brucea javanica oil and doxorubicin. Langmuir, 35 (45), 14532–14542.
  • Liu, H., et al., 2013. Protein-bearing cubosomes prepared by liquid precursor dilution: inner ear delivery and pharmacokinetic study following intratympanic administration. Journal of biomedical nanotechnology, 9 (10), 1784–1793.
  • Liu, H., et al., 2016. Reinforcement of injectable calcium phosphate cement by gelatinized starches. Journal of biomedical materials research. Part B, applied biomaterials, 104 (3), 615–625.
  • Lowry, G.V., et al., 2016. Guidance to improve the scientific value of zeta-potential measurements in nanoEHS. Environmental science: Nano, 3 (5), 953–965.
  • Morsi, N.M., Abdelbary, G.A., and Ahmed, M.A., 2014. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. European journal of pharmaceutics and biopharmaceutics, 86 (2), 178–189.
  • Nakano, M., et al., 2001. Small-angle X-ray scattering and 13C NMR investigation on the internal structure of “cubosomes”. Langmuir, 17 (13), 3917–3922.
  • Nandi, S.K., et al., 2009. Local antibiotic delivery systems for the treatment of osteomyelitis–a review. Materials science engineering: C, 29 (8), 2478–2485.
  • Nijhof, M.W., et al., 2000. Prophylaxis of implant‐related staphylococcal infections using tobramycin‐containing bone cement. Journal of biomedical materials research, 52 (4), 754–761.
  • Nnamani, P.O., et al., 2021. Formulation and evaluation of transdermal nanogel for delivery of artemether. Drug delivery translational research, 11, 1–20.
  • Pan, X., et al., 2013. Nanostructured cubosomes as advanced drug delivery system. Current pharmaceutical design, 19 (35), 6290–6297.
  • Passoni, M.H., and Salgado, H., 2012. Development and validation of a new and rapid HPLC for determination of lyophilized teicoplanin. Analytical methods, 4 (6), 1560–1564.
  • Patel, M.R., et al., 2016. Novel microemulsion-based gel formulation of tazarotene for therapy of acne. Pharmaceutical development and technology, 21 (8), 921–932.
  • Shabbir, M., et al., 2020. Lipid vesicles and nanoparticles for non-invasive topical and transdermal drug delivery. Current pharmaceutical design, 26 (18), 2149–2166.
  • Smeltzer, M.S., et al., 1997. Characterization of a rabbit model of staphylococcal osteomyelitis. Journal of orthopaedic research, 15 (3), 414–421.
  • Tilley, A.J., Drummond, C.J., and Boyd, B.J., 2013. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions. Journal of colloid and interface science, 392, 288–296.
  • Wei, Y., et al., 2019. Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine. RSC advances, 9 (11), 6287–6298.
  • Yang, J., et al., 2021. Current opinions on the mechanism, classification, imaging diagnosis and treatment of post-traumatic osteomyelitis. Chinese journal of traumatology = zhonghua chuang shang za zhi, 24 (6), 320–327.
  • Yang, Z., et al., 2011. Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes. Journal of nanomaterials 2011, 1–10.
  • Yang, Z., et al., 2012. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech, 13 (4), 1483–1491.
  • Younes, N.F., Abdel-Halim, S.A., and Elassasy, A.I., 2018. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. International journal of pharmaceutics, 553 (1–2), 386–397.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.